P3 Health Partners Inc. (PIIIW)
USD 0.01
(-15.5%)
USD 0.01
(-15.5%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.26 Billion USD | 20.66% |
| 2022 | 1.04 Billion USD | -99.79% |
| 2021 | 491.06 Billion USD | 101037.34% |
| 2020 | 485.54 Million USD | 233.75% |
| 2019 | 145.48 Million USD | 65.89% |
| 2018 | 87.69 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 388.48 Million USD | 12.0% |
| 2024 Q2 | 379.15 Million USD | -2.4% |
| 2023 FY | 1.26 Billion USD | 20.66% |
| 2023 Q2 | 329.08 Million USD | 8.94% |
| 2023 Q4 | 346.86 Million USD | 20.29% |
| 2023 Q3 | 288.35 Million USD | -12.38% |
| 2023 Q1 | 302.07 Million USD | 16.99% |
| 2022 FY | 1.04 Billion USD | -99.79% |
| 2022 Q4 | 258.2 Million USD | 4.0% |
| 2022 Q3 | 248.26 Million USD | -7.87% |
| 2022 Q2 | 269.45 Million USD | -1.5% |
| 2022 Q1 | 273.54 Million USD | -99.94% |
| 2021 Q1 | 151.29 Million USD | 16.03% |
| 2021 FY | 491.06 Billion USD | 101037.34% |
| 2021 Q4 | 490.6 Billion USD | 313344.81% |
| 2021 Q3 | 156.52 Million USD | 3.37% |
| 2021 Q2 | 151.41 Million USD | 0.08% |
| 2020 Q4 | 130.39 Million USD | 1.21% |
| 2020 Q2 | 116.86 Million USD | 1.66% |
| 2020 Q1 | 114.95 Million USD | 0.0% |
| 2020 Q3 | 128.84 Million USD | 10.25% |
| 2020 FY | 485.54 Million USD | 233.75% |
| 2019 FY | 145.48 Million USD | 65.89% |
| 2018 FY | 87.69 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 56.76% |
| Addus HomeCare Corporation | 1.05 Billion USD | -19.622% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | -546.383% |
| Amedisys, Inc. | 2.23 Billion USD | 43.374% |
| American Oncology Network, Inc. | 1.27 Billion USD | 1.001% |
| Astrana Health, Inc. | 1.38 Billion USD | 8.675% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | 33.18% |
| IMAC Holdings, Inc. | 5.19 Million USD | -24267.424% |
| biote Corp. | 185.36 Million USD | -583.198% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -3940.286% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | 37.3% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | -102.851% |
| The Ensign Group, Inc. | 3.72 Billion USD | 66.043% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | 24.232% |
| InnovAge Holding Corp. | 763.85 Million USD | -65.787% |
| Assure Holdings Corp. | 255 Thousand USD | -496517.647% |
| The Joint Corp. | 117.69 Million USD | -975.968% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | -19.96% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -12125.447% |
| ModivCare Inc. | 2.75 Billion USD | 53.97% |
| NewGenIvf Group Limited | 5.13 Million USD | -24556.1% |
| Novo Integrated Sciences, Inc. | 12.57 Million USD | -9972.964% |
| Option Care Health, Inc. | 4.3 Billion USD | 70.565% |
| P3 Health Partners Inc. | 1.26 Billion USD | 0.0% |
| The Pennant Group, Inc. | 544.89 Million USD | -132.409% |
| Surgery Partners, Inc. | 2.74 Billion USD | 53.838% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -22861.776% |
| Talkspace, Inc. | 150.04 Million USD | -743.997% |
| Talkspace, Inc. | 150.04 Million USD | -743.997% |
| The Oncology Institute, Inc. | 324.23 Million USD | -290.568% |
| The Oncology Institute, Inc. | 324.23 Million USD | -290.568% |